Adam Koster

Adam Koster is an experienced executive in the biopharmaceutical industry, currently serving as the Chief Executive Officer at Interactome Biotherapeutics since March 2020. Prior to this role, Adam held the position of Chief Business Officer at Kimera Labs Inc from September 2017 to March 2020 and worked as the Regional Business Manager at Curonix from January 2016 to September 2017. Adam is furthering professional education through an Executive MBA program at the University of Notre Dame - Mendoza College of Business, anticipated to be completed in April 2026, and possesses a Bachelor of Science in Neuroscience from Central Michigan University.